More severe hypercoagulable state in acute COVID-19 pneumonia as compared to other pneumonia.

CFT, clot formation time CT, clotting time MCF, maximum clot firmness aPTT, activated partial thromboplastin time listPT, prothrombin time

Journal

Mayo Clinic proceedings. Innovations, quality & outcomes
ISSN: 2542-4548
Titre abrégé: Mayo Clin Proc Innov Qual Outcomes
Pays: Netherlands
ID NLM: 101728275

Informations de publication

Date de publication:
12 Apr 2021
Historique:
received: 25 06 2020
revised: 18 08 2020
accepted: 21 08 2020
entrez: 19 4 2021
pubmed: 20 4 2021
medline: 20 4 2021
Statut: aheadofprint

Résumé

To conduct a comprehensive evaluation of coagulation profiles - via traditional and whole blood thromboelastometry tests - in COVID-19 positive vs. COVID-19 negative patients admitted to medical wards for acute pneumonia. We enrolled all consecutive patients admitted to Internal Medicine wards of Padova University Hospital between 7 March and 30 April 2020 for COVID-19-related pneumonia (cases) vs. non-COVID-19 pneumonia (controls). A group of healthy subjects acted as baseline for thromboelastometry parameters. Fifty-six cases (mean age 64±15 yrs, M/F 37/19) and 56 controls (mean age 76±11 yrs, M/F 35/21) were enrolled. Cases and controls showed markedly hypercoagulable thromboelastometry profiles vs. healthy subjects, mainly characterized by a significantly shorter propagation phase of coagulation (Clot Formation Time, CFT) and significantly increased maximum clot firmness (MCF) (p <0.001 in all comparisons). COVID-19 patients with pneumonia had significantly shorter CFT and higher MCF (p <0.01 and <0.05, respectively in all comparisons) vs. controls. Patients admitted to internal medicine wards for COVID-19 pneumonia presented a markedly prothrombotic state, which seems peculiar to COVID-19 rather than pneumonia itself.

Identifiants

pubmed: 33870099
doi: 10.1016/j.mayocpiqo.2020.08.014
pii: S2542-4548(21)00043-6
pmc: PMC8041140
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

.

Auteurs

Luca Spiezia (L)

General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy.

Elena Campello (E)

General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy.

Marco Cola (M)

Infectious Diseases, Padova University Hospital, Padova Italy.

Francesco Poletto (F)

General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy.

Lorenzo Cerruti (L)

General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy.

Anna Poretto (A)

General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy.

Chiara Simion (C)

General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy.

Annamaria Cattelan (A)

Infectious Diseases, Padova University Hospital, Padova Italy.

Roberto Vettor (R)

Internal Medicine 3, Department of Medicine, Padova University Hospital, Padova, Italy.

Paolo Simioni (P)

General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy.

Classifications MeSH